Skip to content

Dr. IRIS KNOCKAERT

Active Private limited companyfounded 2006active for 20 yearsWillem van Saeftingestraat 8, 8380 BrugesKBO/BCE: BE 0881.681.597

Lifetime

19 annual accounts with figures on one time axis
peak of €185,480 in 2024
€173,881▼ 6.3%
peak of €128,831 in 2024
€121,069▼ 6.0%
peak of €614,681 in 2024
€490,749▼ 20.2%
€59,475▼ 49.0%
Board1 name since 2021
1 director
Documentsfilings and deeds
31-08-202631 days late
2025micro format
Dividend €245,000Equity from €614,681 to €490,749Debts from €116,542 to €59,475Cash from €529,534 to €161,527

Key points

from the 2025 annual accounts

Equity

€490,749 ▼ 20.2%
614,6812024+121,069Profit-245,000Dividend490,7492025

Dr. IRIS KNOCKAERT paid out €245,000 in dividends. That is 202% of the 2025 profit.

Turnover

≈ €310,000 estimated

The micro format states no turnover.

Filings

19 annual accounts since 2007
AprilJune31 JulyOctober2010201520202025

Five of the last ten came late. The 2021 accounts came in latest, 31 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,155 companies had the same profile as Dr. IRIS KNOCKAERT has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,155 companies, not a prediction for Dr. IRIS KNOCKAERT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director

Shares in 1 company,

Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0881681597
reappointed as statutory director Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 10-03-2023 · Gazette deed
New establishment in Blankenberge Pater Pirelaan 7
Algemene Vergadering - Boekjaar General meeting of 02-08-2017 · Gazette deed
All 34 events

Comparable companies

same main activity, similar in size and age
Company
Dr. IRIS KNOCKAERT Bruges €550,224 €173,881 89.2% -
DOKTER SANDY KYNDT Koksijde €501,891 €174,511 87.5% -
DR. STIJN DECRAENE Avelgem €545,556 €160,957 96.7% -
DR. BENE VANBESIEN Poperinge €542,540 €170,254 94.7% -
Dr. Marc Bloquiaux Waregem €531,918 €191,458 88.9% -
CAUDRON HILDE DOKTERSVENNOOTSCHAP Wielsbeke €518,203 €194,093 90.1% -
DR. RIA LEENDERS Dilsen-Stokkem €504,115 €175,275 84.3% -

These companies have the same main activity as Dr. IRIS KNOCKAERT: general medical practice (NACE 86210). They are comparable in size and age: total assets between €502,000 and €546,000, founded between 2003 and 2008.

Official details

Source: KBO
Status
Active since 06-06-2006Normal situation
Activity
General medical practiceNACE 86210and 1 other
Establishment units
2.191.123.6948380 Bruges, since 06-06-2006
2.319.785.2868370 Blankenberge, since 01-10-2020
Financial year end
31 December
Peppol
Reachable since 10-10-2025
Company details

Annual accounts 2025

€550,224▼ 24.8%
Filing
Filed on 31-08-2026
Financials

Insights on Dr. IRIS KNOCKAERT

Dr. IRIS KNOCKAERT files the micro format. That format states no turnover. The gross margin rose from €162,888 in 2007 to €173,881 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. IRIS KNOCKAERT

What is the company number of Dr. IRIS KNOCKAERT?
The company number of Dr. IRIS KNOCKAERT is 0881.681.597. The VAT number is the same number with BE in front: BE 0881.681.597.
Where is Dr. IRIS KNOCKAERT based?
The registered office is at Willem van Saeftingestraat 8, 8380 Bruges.Company details
What does Dr. IRIS KNOCKAERT do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. IRIS KNOCKAERT?
Dr. IRIS KNOCKAERT is a private limited company (BV).
When was Dr. IRIS KNOCKAERT founded?
Dr. IRIS KNOCKAERT was founded on 06-06-2006.
Is Dr. IRIS KNOCKAERT still active?
Yes, Dr. IRIS KNOCKAERT is an active enterprise in the KBO register.
What is the turnover of Dr. IRIS KNOCKAERT?
The turnover in financial year 2025 is about €310,000. This figure is estimated from the gross margin of €173,881 and 30 comparable companies (NACE 86210). It probably lies between €250,000 and €390,000.Financials
Is Dr. IRIS KNOCKAERT profitable?
In financial year 2025, Dr. IRIS KNOCKAERT made a profit of €121,069.
Where can I find the annual accounts of Dr. IRIS KNOCKAERT?
Dr. IRIS KNOCKAERT filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. IRIS KNOCKAERT due?
Dr. IRIS KNOCKAERT must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.